{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:28:04Z","timestamp":1774992484626,"version":"3.50.1"},"reference-count":42,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5551\/jat.38265","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T17:08:34Z","timestamp":1481044114000},"page":"110-119","source":"Crossref","is-referenced-by-count":52,"title":["Intestinal Immunity and Gut Microbiota in Atherogenesis"],"prefix":"10.5551","volume":"24","author":[{"given":"Tomoya","family":"Yamashita","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008; 359: 2195-2207","DOI":"10.1056\/NEJMoa0807646"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Koga J, Matoba T, Egashira K: Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases. J Atheroscler Thromb, 2016; 23: 757-765","DOI":"10.5551\/jat.35113"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Usman A, Ribatti D, Sadat U, Gillard JH: From Lipid Retention to Immune-Mediate Inflammation and Associated Angiogenesis in the Pathogenesis of Atherosclerosis. J Atheroscler Thromb, 2015; 22: 739-749","DOI":"10.5551\/jat.30460"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Eguchi K, Manabe I: Toll-Like Receptor, Lipotoxicity and Chronic inflammation: The Pathological Link Between Obesity and Cardiometabolic Disease. J Atheroscler Thromb, 2014; 21: 629-639","DOI":"10.5551\/jat.22533"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-126","DOI":"10.1056\/NEJM199901143400207"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Libby P, Lichtman AH, Hansson GK: Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity, 2013; 38: 1092-1104","DOI":"10.1016\/j.immuni.2013.06.009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yodoi K, Yamashita T, Sasaki N, Kasahara K, Emoto T, Matsumoto T, Kita T, Sasaki Y, Mizoguchi T, Sparwasser T, Hirata K: Foxp3+ regulatory T cells play a protective role in angiotensin II-induced aortic aneurysm formation in mice. Hypertension, 2015; 65: 889-895","DOI":"10.1161\/HYPERTENSIONAHA.114.04934"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kita T, Yamashita T, Sasaki N, Kasahara K, Sasaki Y, Yodoi K, Takeda M, Nakajima K, Hirata K: Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovsac Res, 2014; 102: 107-117","DOI":"10.1093\/cvr\/cvu002"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Kasahara K, Sasaki N, Yamashita T, Kita T, Yodoi K, Sasaki Y, Takeda M, Hirata K: CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. J Am Heart Assoc, 2014; 3: e000719. doi: 10.1161\/JAHA.113.000719","DOI":"10.1161\/JAHA.113.000719"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nakajima K, Yamashita T, Kita T, Takeda M, Sasaki N, Kasahara K, Shinohara M, Rikitake Y, Ishida T, Yokoyama M, Hirata K: Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol, 2011; 31: 1963-1972","DOI":"10.1161\/ATVBAHA.111.229443"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K: Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation, 2009; 120: 1996-2005","DOI":"10.1161\/CIRCULATIONAHA.109.863431"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, Ishida T, Hirata K: Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol, 2010; 30: 2495-2503","DOI":"10.1161\/ATVBAHA.110.215459"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Round JL, Mazmanian SK: The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol, 2009; 9: 313-323","DOI":"10.1038\/nri2515"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Weiner HL, da Cunha AP, Quintana F, Wu H: Oral tolerance. Immunol Rev, 2011; 241: 241-259","DOI":"10.1111\/j.1600-065X.2011.01017.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso AS, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL: Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells. Nat Med, 2006; 12: 627-635","DOI":"10.1038\/nm1408"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ishikawa H, Ochi H, Chen ML, Frenkel D, Maron R, Weiner HL: Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody. Diabetes, 2007; 56: 2103-2109","DOI":"10.2337\/db06-1632"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Human Microbiome Project Consortium: Structure, function and diversity of the healthy human microbiome. Nature, 2012; 486: 207-214","DOI":"10.1038\/nature11234"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Dor\u00e9 J; MetaHIT Consortium, Antol\u00edn M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, M\u00e9rieux A, Melo Minardi R, M'rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P: Enterotypes of the human gut microbiome. Nature, 2011; 473: 174-180","DOI":"10.1038\/nature09944"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R: Diversity, stability and resilience of the human gut microbiota. Nature, 2012; 489: 220-230","DOI":"10.1038\/nature11550"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, Kim S, Fritz JV, Wilmes P, Ueha S, Matsushima K, Ohno H, Olle B, Sakaguchi S, Taniguchi T, Morita H, Hattori M, Honda K: Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature, 2013; 500: 232-236","DOI":"10.1038\/nature12331"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K: Induction of colonic regulatory T cells by indigenous Clostridium species. Science, 2011; 331: 337-341","DOI":"10.1126\/science.1198469"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H: Commensal microbe derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 2013; 504: 446-450","DOI":"10.1038\/nature12721"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI: A core gut microbiome in obese and lean twins. Nature, 2009; 457: 480-484","DOI":"10.1038\/nature07540"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature, 2006; 444: 1022-1023","DOI":"10.1038\/4441022a"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006; 444: 1027-1031","DOI":"10.1038\/nature05414"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, Deng L, Bry L, Gordon JI, Kahn CR: Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. Cell Metab, 2015; 22: 516-530","DOI":"10.1016\/j.cmet.2015.07.007"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, Hankir M, Zhang S, Carling D, Swann JR, Gibson G, Viardot A, Morrison D, Louise Thomas E, Bell JD: The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun, 2014; 5: 3611","DOI":"10.1038\/ncomms4611"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 2012; 490: 55-60","DOI":"10.1038\/nature11450"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Karlsson FH, Tremaroli V, Nookaew I, Bergstr\u00f6m G, Behre CJ, Fagerberg B, Nielsen J, B\u00e4ckhed F: Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 2013; 498: 99-103","DOI":"10.1038\/nature12198"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, Komiya K, Kawaguchi M, Shimizu T, Ogihara T, Tamura Y, Sakurai Y, Yamamoto R, Mita T, Fujitani Y, Fukuda H, Nomoto K, Takahashi T, Asahara T, Hirose T, Nagata S, Yamashiro Y, Watada H: Gut dysbiosis and detection of \u201clive gut bacteria\u201d in blood of Japanese patients with type 2 diabetes. Diabetes Care, 2014; 37: 2343-2350","DOI":"10.2337\/dc13-2817"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L; MICRO-Obes Consortium, Dumas ME, Rizkalla SW, Dor\u00e9 J, Cani PD, Cl\u00e9ment K: Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut, 2016; 65: 426-436","DOI":"10.1136\/gutjnl-2014-308778"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL: Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 2011; 472: 57-63","DOI":"10.1038\/nature09922"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med, 2013; 368: 1575-1584","DOI":"10.1056\/NEJMoa1109400"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Tang WH, Hazen SL: The contributory role of gut microbiota in cardiovascular disease. J Clin Invest, 2016; 124: 4204-4211","DOI":"10.1172\/JCI72331"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, DiDonato AJ, Fu X, Hazen JE, Krajcik D, DiDonato JA, Lusis AJ, Hazen SL: Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell, 2015; 163: 1585-1595","DOI":"10.1016\/j.cell.2015.11.055"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med, 2013; 19: 576-585","DOI":"10.1038\/nm.3145"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, Org E, Wu Y, Li L, Smith JD, Tang WH, DiDonato JA, Lusis AJ, Hazen SL: \u03b3-butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab, 2014; 20: 799-812","DOI":"10.1016\/j.cmet.2014.10.006"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Wright SD, Burton C, Hernandez M, Hassing H, Montenegro J, Mundt S, Patel S, Card DJ, Hermanowski-Vosatka A, Bergstrom JD, Sparrow CP, Detmers PA, Chao YS: Infectious agents are not necessary for murine atherogenesis. J Exp Med, 2000; 191: 1437-1442","DOI":"10.1084\/jem.191.8.1437"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Stepankova R, Tonar Z, Bartova J, Nedorost L, Rossman P, Poledne R, Schwarzer M, Tlaskalova-Hogenova H: Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J Atheroscler Thromb, 2010; 17: 796-804","DOI":"10.5551\/jat.3285"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, Felin J, Perkins R, Bor\u00e9n J, Oresic M, B\u00e4ckhed F: The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res, 2010; 51: 1101-1112","DOI":"10.1194\/jlr.M002774"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Karlsson FH, Fak F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, B\u00e4ckhed F, Nielsen J: Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 2012; 3: 1245","DOI":"10.1038\/ncomms2266"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, Kasahara K, Yodoi K, Matsumoto T, Mizoguchi T, Ogawa W, Hirata K: Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb, 2016; 23: 908-921","DOI":"10.5551\/jat.32672"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/2\/24_38265\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:22:32Z","timestamp":1498353752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/2\/24_38265\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.38265","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}